You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 4
  • 388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients

Article metrics

Article menu

Download PDFPDF

Palliative care
388 Efficacy of individualised starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator assessment (IA) in newly diagnosed advanced ovarian cancer (OC) patients
Free

 

Online download statistics by month:

Online download statistics by month: December 2020 to October 2024

AbstractFullPdf
Dec 202056011
Jan 20214709
Feb 20211606
Mar 20212705
Apr 20211703
May 2021706
Jun 2021107
Jul 2021002
Aug 20210010
Sep 2021104
Oct 202114019
Nov 202120010
Dec 20211402
Jan 20221601
Feb 20221906
Mar 20221804
Apr 20221404
May 20221808
Jun 20222103
Jul 20222802
Aug 20222508
Sep 20223308
Oct 20222003
Nov 20221405
Dec 20223802
Jan 20232903
Feb 20232000
Mar 20231602
Apr 20231401
May 2023401
Jun 20231706
Jul 20231304
Aug 20231502
Sep 2023501
Oct 20231203
Nov 20232305
Dec 20233100
Jan 2024800
Feb 2024800
Mar 2024260138
Apr 20242406
May 20241502
Jun 20244201
Jul 20241006
Aug 20242907
Sep 20242600
Oct 2024201
Total8730337